Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company’s plant at Goa.
The company’s formulations manufacturing facility at Goa has received an EIR from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing today.
This receipt indicates successful closure of the inspection and queries raised during the audit, it added.
The inspection that was carried out between March 14-20, 2017 has now been closed by the regulator, the company said.
Shares of Unichem Laboratories were trading 2.10 per cent higher at Rs 265.55 per scrip on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.